84 related articles for article (PubMed ID: 8311652)
1. Apolipoproteins and lipids in coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristic plots and areas.
Zweig MH
Arch Pathol Lab Med; 1994 Feb; 118(2):141-4. PubMed ID: 8311652
[TBL] [Abstract][Full Text] [Related]
2. ROC curve analysis: an example showing the relationships among serum lipid and apolipoprotein concentrations in identifying patients with coronary artery disease.
Zweig MH; Broste SK; Reinhart RA
Clin Chem; 1992 Aug; 38(8 Pt 1):1425-8. PubMed ID: 1643709
[TBL] [Abstract][Full Text] [Related]
3. Comparison of apolipoprotein B and non-high-density lipoprotein cholesterol for identifying coronary artery disease risk based on receiver operating curve analysis.
Levinson SS
Am J Clin Pathol; 2007 Mar; 127(3):449-55. PubMed ID: 17276939
[TBL] [Abstract][Full Text] [Related]
4. Relationship between bilirubin, apolipoprotein B, and coronary artery disease.
Levinson SS
Ann Clin Lab Sci; 1997; 27(3):185-92. PubMed ID: 9142370
[TBL] [Abstract][Full Text] [Related]
5. Optimized automated apolipoprotein A-I assays as markers for coronary artery disease.
Levinson SS; Hobbs GA
Arch Pathol Lab Med; 1997 Jul; 121(7):678-84. PubMed ID: 9240901
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
Gauri AJ; Raxwal VK; Roux L; Fearon WF; Froelicher VF
Am Heart J; 2001 Jul; 142(1):136-41. PubMed ID: 11431669
[TBL] [Abstract][Full Text] [Related]
7. On linear combinations of biomarkers to improve diagnostic accuracy.
Liu A; Schisterman EF; Zhu Y
Stat Med; 2005 Jan; 24(1):37-47. PubMed ID: 15515132
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variants that relate to disorders of lipid transport in Spanish subjects with premature coronary artery disease.
Masana L; Febrer G; Cavanna J; Baroni MG; Marz W; Hoffmann MM; Shine B; Galton DJ
Clin Sci (Lond); 2001 Feb; 100(2):183-90. PubMed ID: 11171287
[TBL] [Abstract][Full Text] [Related]
9. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.
Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A
Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of apolipoproteins is better than routinely measured traditional lipids].
Kallner A; Estonius M
Lakartidningen; 2006 Mar 8-14; 103(10):753-6, 758. PubMed ID: 16610202
[No Abstract] [Full Text] [Related]
11. The risk of coronary heart disease in men with androgenetic alopecia.
Sasmaz S; Senol M; Ozcan A; Dogan G; Tuncer C; Akyol O; Sener S
J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):123-5. PubMed ID: 10343940
[TBL] [Abstract][Full Text] [Related]
12. The role of exercise in modulating the impact of an ultralow-fat diet on serum lipids and apolipoproteins in patients with or at risk for coronary artery disease.
Marshall DA; Vernalis MN; Remaley AT; Walizer EM; Scally JP; Taylor AJ
Am Heart J; 2006 Feb; 151(2):484-91. PubMed ID: 16442919
[TBL] [Abstract][Full Text] [Related]
13. Receiver operating characteristic (ROC) curves and the definition of threshold levels to diagnose coronary artery disease on electrocardiographic stress testing. Part II: the use of ROC curves in the choice of electrocardiographic stress test markers of ischaemia.
Marazìa S; Barnabei L; De Caterina R
J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):22-31. PubMed ID: 18268415
[TBL] [Abstract][Full Text] [Related]
14. Role of lipid and lipoprotein profiles in risk assessment and therapy.
Ballantyne CM; Hoogeveen RC
Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
[TBL] [Abstract][Full Text] [Related]
15. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
Onat A
Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
[TBL] [Abstract][Full Text] [Related]
16. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
Sharma R; Mahajan M; Singh B; Bal BS; Kant R
J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
[TBL] [Abstract][Full Text] [Related]
19. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease.
Mansfield E; McPherson R; Koski KG
J Am Diet Assoc; 1999 Nov; 99(11):1373-9. PubMed ID: 10570674
[TBL] [Abstract][Full Text] [Related]
20. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
